Search In this Thesis
   Search In this Thesis  
العنوان
Comparative Study between Three Therapeutic Options for Treatment of chronic Obstructive Pulmonary Disease Patients /
المؤلف
Gerab, Noran Salah Lotfy.
هيئة الاعداد
باحث / نوران صلاح لطفي جراب
مشرف / جمال عبدالخالق العزب
مناقش / غاده عاطف عطيه
مناقش / سحر محمد النجار
الموضوع
Clinical Pharmacy.
تاريخ النشر
2021.
عدد الصفحات
p 110. :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
العلوم الصيدلية
تاريخ الإجازة
10/8/2021
مكان الإجازة
جامعة طنطا - كلية الصيدلة - Clinical Pharmacy
الفهرس
Only 14 pages are availabe for public view

from 142

from 142

Abstract

Chronic obstructive pulmonary disease (COPD) is associated with abnormal inflammatory response of the lungs towards noxious particles and gases, usually from cigarette smoke. Symptomatic COPD patients can be managed with one of the following inhaled medications: long-acting betaagonists LABA); long acting muscarinic antagonists (LAMA); or inhaled corticosteroids (ICS) [1]. Administration of two or more medications from different classes seems beneficial when the disease cannot be controlled adequately with LAMA or LABA mono-therapy [1]. LAMAs dilate the airway by selectively blocking acetylcholine muscarinic (M3) receptors [2.LABAs are β2-agonists, which provide smooth muscle relaxation by stimulating β2-adrenergic receptors [3]. Furthermore, LAMAs and LABAs were reported to exert an anti-inflammatory activity [2,4-5]. LAMAs and LABAs are considered ideal treatments for symptomatic COPD patients through improving lung function, exercise capacity, and quality of life, and reducing exacerbations [6-7].